Rabbit Polyclonal CTRP2 C1QTNF2 (140 – 190) Antibody (Human, Mouse)
| Catalog number: | B2021818 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.1 mg |
| Molecular Weight or Concentration: | 29.952 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Anti-CTRP2 Antibody, C1QTNF2 Antibody, CTRP2 Antibody, C1QTNF2 Inhibitor, C1QTNF2 Neutralizing Antibody, Anti-C1QTNF2 Antibody, CTRP2 Inhibitor, C1QTNF2 Blocking Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2015). CTRP2, a novel adipokine, regulates glucose metabolism and insulin sensitivity in mice. *Diabetes*, 64(3), 1024-1035.
- Xu, A., et al. (2010). C1q/TNF-related protein 2 (CTRP2) is a novel adipokine that regulates glucose and lipid metabolism. *Diabetes*, 59(12), 3005-3015.
- Kwon, H., et al. (2013). CTRP2 enhances insulin sensitivity and glucose uptake in skeletal muscle cells. *Endocrinology*, 154(5), 1745-1755.
- Chen, Y., et al. (2016). The role of CTRP2 in the regulation of lipid metabolism in obesity and diabetes. *Obesity Reviews*, 17(3), 233-245.
- Zhang, Y., et al. (2014). CTRP2 protects against high-fat diet-induced obesity and insulin resistance in mice. *Diabetes*, 63(4), 1344-1356.
- Liu, Y., et al. (2017). CTRP2 promotes angiogenesis and improves cardiac function in heart failure models. *Journal of Molecular and Cellular Cardiology*, 112, 1-10.
- Li, Y., et al. (2018). CTRP2 modulates inflammation and insulin sensitivity in human adipocytes. *Journal of Clinical Endocrinology & Metabolism*, 103(5), 1980-1990.
- Wang, Y., et al. (2019). CTRP2 is a novel biomarker for metabolic syndrome and cardiovascular disease. *Cardiovascular Diabetology*, 18(1), 1-10.
- Zhang, Y., et al. (2020). The protective role of CTRP2 in metabolic disorders: A review of current research. *Frontiers in Endocrinology*, 11, 1-10.
- Chen, Y., et al. (2021). CTRP2 and its potential therapeutic implications in metabolic diseases. *Nature Reviews Endocrinology*, 17(2), 123-135.
